Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Date

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Nanomedicine (London, England)|October 27, 2011
Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluationAbhijit A Date, Deepika Srivastava, Mangal S Nagarsenker, et al.
MMWR. Morbidity and Mortality Weekly Report|October 3, 2014
Typhoid Fever surveillance and vaccine use - South-East Asia and Western Pacific regions, 2009-2013Kashmira A Date, Adwoa D Bentsi-Enchill, Kimberley K Fox, et al.
Molecular Pharmaceutics|April 13, 2011
Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administrationAbhijit A Date, Mangal S Nagarsenker, Shilpa Patere, et al.
Annals of Saudi Medicine|February 1, 2007
Schistosomiasis in patients in the Sultanate of OmanE M Scrimgeour, A Ahmed, J Sallam, et al.
Public Health Action|May 6, 2020
Improving sputum collection processes to increase tuberculosis case finding among HIV-positive persons in BotswanaU Mathebula, C Emerson, T Agizew, et al.
International Journal of Pharmaceutics|February 22, 2026
Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infectionSudipta Mallick, Pankaj Sharma, Tejabhiram Yadavalli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 5, 2017
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel diseaseAbhijit A Date, Rana Rais, Taarika Babu, et al.
Cancer Letters|May 23, 2026
Kinase-independent signaling by PIM1 promotes drug resistance by increasing mitophagy and reducing oxidative stressHope Liou, Shailender S Chauhan, Caitlyn E Flores, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV InfectionPeng Xiao, Sanjeev Gumber, Mark A Marzinke, et al.
The Journal of Infectious Diseases|April 19, 2008
Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university populationAnand A Date, Moe H Kyaw, Alison M Rue, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Nanomedicine (London, England)|October 27, 2011
Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluationAbhijit A Date, Deepika Srivastava, Mangal S Nagarsenker, et al.
MMWR. Morbidity and Mortality Weekly Report|October 3, 2014
Typhoid Fever surveillance and vaccine use - South-East Asia and Western Pacific regions, 2009-2013Kashmira A Date, Adwoa D Bentsi-Enchill, Kimberley K Fox, et al.
Molecular Pharmaceutics|April 13, 2011
Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administrationAbhijit A Date, Mangal S Nagarsenker, Shilpa Patere, et al.
Annals of Saudi Medicine|February 1, 2007
Schistosomiasis in patients in the Sultanate of OmanE M Scrimgeour, A Ahmed, J Sallam, et al.
Public Health Action|May 6, 2020
Improving sputum collection processes to increase tuberculosis case finding among HIV-positive persons in BotswanaU Mathebula, C Emerson, T Agizew, et al.
International Journal of Pharmaceutics|February 22, 2026
Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infectionSudipta Mallick, Pankaj Sharma, Tejabhiram Yadavalli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 5, 2017
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel diseaseAbhijit A Date, Rana Rais, Taarika Babu, et al.
Cancer Letters|May 23, 2026
Kinase-independent signaling by PIM1 promotes drug resistance by increasing mitophagy and reducing oxidative stressHope Liou, Shailender S Chauhan, Caitlyn E Flores, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV InfectionPeng Xiao, Sanjeev Gumber, Mark A Marzinke, et al.
The Journal of Infectious Diseases|April 19, 2008
Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university populationAnand A Date, Moe H Kyaw, Alison M Rue, et al.
Pageof 21